Product NDC: | 0172-5241 |
Proprietary Name: | Anagrelide Hydrochloride |
Non Proprietary Name: | Anagrelide Hydrochloride |
Active Ingredient(s): | .5 mg/1 & nbsp; Anagrelide Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0172-5241 |
Labeler Name: | IVAX Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076468 |
Marketing Category: | ANDA |
Start Marketing Date: | 20050418 |
Package NDC: | 0172-5241-60 |
Package Description: | 100 CAPSULE in 1 BOTTLE (0172-5241-60) |
NDC Code | 0172-5241-60 |
Proprietary Name | Anagrelide Hydrochloride |
Package Description | 100 CAPSULE in 1 BOTTLE (0172-5241-60) |
Product NDC | 0172-5241 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Anagrelide Hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20050418 |
Marketing Category Name | ANDA |
Labeler Name | IVAX Pharmaceuticals, Inc. |
Substance Name | ANAGRELIDE HYDROCHLORIDE |
Strength Number | .5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Decreased Platelet Production [PE],Platelet-reducing Agent [EPC],Phosphodiesterase 3 Inhibitors [MoA] |